Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2442 Views
-
Last post by NHE
-
- 6 Replies
- 6960 Views
-
Last post by ElliotB
-
- 0 Replies
- 1403 Views
-
Last post by NHE
-
- 0 Replies
- 3610 Views
-
Last post by NHE
-
- 1 Replies
- 1086 Views
-
Last post by NHE
-
- 1 Replies
- 1617 Views
-
Last post by NHE
-
- 11 Replies
- 3474 Views
-
Last post by NHE
-
- 0 Replies
- 3331 Views
-
Last post by NHE
-
- 0 Replies
- 1535 Views
-
Last post by NHE